Clayton Yates - Aug 25, 2023 Form 3 Insider Report for Genvor Inc (GNVR)

Role
Chief Scientific Officer, Director, 10%+ Owner
Signature
/s/ Dr. Clayton Yates
Stock symbol
GNVR
Transactions as of
Aug 25, 2023
Transactions value $
$0
Form type
3
Date filed
11/14/2023, 12:54 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GNVR Series B Preferred Stock Aug 25, 2023 Common Stock 7.31M ACT Holdings, LLC F1
holding GNVR Series A Preferred Stock Aug 25, 2023 Common Stock 3 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Yates may be deemed to be the beneficial owner of 731,262 shares of the issuer's Series B Preferred Stock, held in the name of ACT Holdings, LLC. Each share of Series B Preferred Stock is convertible at the election of the holder into 10 shares of common stock, such that 7,312,620 shares of common stock are issuable upon conversion of ACT Holdings, LLC's Series B Preferred Stock.
F2 Dr. Yates owns 3 shares of the issuer's Series A Preferred Stock. Each share of Series A Preferred Stock is convertible at the election of the holder into 1 share of common stock, such that 3 shares of common stock are issuable upon conversion of Dr. Yates' Series A Preferred Stock.